RepliCel has planned a Phase 1/2 Achilles tendinosis clinical trial using fibroblasts that are isolated from the nonbulbar dermal sheath cells of a hair follicle, and is recruiting in Q1 2015.
RepliCel has planned a Phase 1/2 Achilles tendinosis clinical trial using fibroblasts. These fibroblasts are isolated from the nonbulbar dermal sheath cells of a hair follicle. RepliCel is recruiting in Q1 2015.